$35 Mil. Timm Medical Acquisition Broadens Endocare Urology Market
This article was originally published in The Gray Sheet
Executive Summary
Endocare's Feb. 21 acquisition of Timm Medical Technolgies provides a much-enlarged customer base for its urology product offering
You may also be interested in...
Cryoablation Or Brachytherapy? Endocare Promotes Prostate First-Line Option
Endocare is hoping that the results of an eight-year 590-patient registry study will convince more urologists to use cryoablation as an alternative to brachytherapy for first-line treatment of prostate cancer
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.